EXON 44

Clinical trials for EXON 44 explained in plain language.

Never miss a new study

Get alerted when new EXON 44 trials appear

Sign up with your email to follow new studies for EXON 44, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Can a targeted infusion slow muscle decline in duchenne? a new trial aims to find out.

Disease control Ongoing

This phase 2 trial tests an experimental drug called AOC 1044 in people with Duchenne muscular dystrophy whose genetic mutation makes them candidates for exon 44 skipping therapy. The drug is given by intravenous infusion. Researchers are evaluating long-term safety and whether i…

Matched conditions: EXON 44

Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

EXON 44

Get alerted when new EXON 44 trials appear

Can a targeted infusion slow muscle decline in duchenne? a new trial aims to find out.